Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Paclitaxel 8 Carboplatin 7 Tirzepatide 3 Observation 3 Cisplatin 3 pembrolizumab 2 dostarlimab 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Blood Specimen Collection 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 semaglutide 1 olaparib 1 montelukast 1 inavolisib 1 enfortumab vedotin 1 ceralasertib 1 camrelizumab 1 apatinib 1 anlotinib 1 Watchful Waiting 1 Vaginal Smears 1 Topotecan 1 Tablets 1 Specimen Handling 1 Sensitivity Training Groups 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Endometrial Neoplasms × Levonorgestrel × Clear all

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡